BIOVIC-B.ST
Price:
$0.762
Market Cap:
$80.29M
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Industry
Biotechnology
IPO Date
2017-03-29
Stock Exchange
STO
Ticker
BIOVIC-B.ST
According to Biovica International AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.62. This represents a change of -70.02% compared to the average of -2.07 of the last 4 quarters.
The mean historical PE Ratio of Biovica International AB (publ) over the last ten years is -16.96. The current -0.62 PE Ratio has changed 265.62% with respect to the historical average. Over the past ten years (40 quarters), BIOVIC-B.ST's PE Ratio was at its highest in in the April 2024 quarter at -0.85. The PE Ratio was at its lowest in in the July 2015 quarter at -55.60.
Average
-16.96
Median
-13.83
Minimum
-42.19
Maximum
-0.74
Discovering the peaks and valleys of Biovica International AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.07%
Maximum Annual PE Ratio = -0.74
Minimum Annual Increase = -84.96%
Minimum Annual PE Ratio = -42.19
Year | PE Ratio | Change |
---|---|---|
2024 | -0.74 | -69.48% |
2023 | -2.44 | -84.96% |
2022 | -16.21 | -48.52% |
2021 | -31.49 | 143.07% |
2020 | -12.96 | 33.78% |
2019 | -9.68 | 7.29% |
2018 | -9.03 | -38.62% |
2017 | -14.70 | -65.15% |
2016 | -42.19 | 39.99% |
2015 | -30.13 | -23.73% |
The current PE Ratio of Biovica International AB (publ) (BIOVIC-B.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.46
5-year avg
-12.77
10-year avg
-16.96
Biovica International AB (publ)’s PE Ratio is greater than Hansa Biopharma AB (publ) (-2.59), greater than Xbrane Biopharma AB (publ) (-1.37), greater than Calliditas Therapeutics AB (publ) (-23.25), greater than BioArctic AB (publ) (-89.84), greater than Cantargia AB (publ) (-1.81),
Company | PE Ratio | Market cap |
---|---|---|
-2.59 | $1.62B | |
-1.37 | $364.05M | |
-23.25 | $11.24B | |
-89.84 | $16.18B | |
-1.81 | $395.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biovica International AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biovica International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biovica International AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Biovica International AB (publ) (BIOVIC-B.ST)?
What is the highest PE Ratio for Biovica International AB (publ) (BIOVIC-B.ST)?
What is the 3-year average PE Ratio for Biovica International AB (publ) (BIOVIC-B.ST)?
What is the 5-year average PE Ratio for Biovica International AB (publ) (BIOVIC-B.ST)?
How does the current PE Ratio for Biovica International AB (publ) (BIOVIC-B.ST) compare to its historical average?